This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Yoshiro Mitome: Innovator in Pharmaceutical Preparations
Introduction
Yoshiro Mitome is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of freeze-dried preparations containing high-purity parathyroid hormone (PTH). His innovative work has led to advancements in the production and testing of these vital compounds.
Latest Patents
Yoshiro Mitome holds 2 patents related to his groundbreaking work. His latest patents focus on freeze-dried preparations that comprise high-purity PTH peptides and one or more PTH analogs. These patents also detail methods for producing these preparations and include test methods for detecting PTH analogs to confirm the purity of the freeze-dried preparations. The inventions address the problem of ensuring the purity of PTH peptides during the manufacturing process, highlighting the importance of controlling exposure to air environments within pharmaceutical production facilities.
Career Highlights
Yoshiro Mitome is associated with Asahi Kasei Pharma Corporation, where he has been instrumental in advancing pharmaceutical technologies. His work has not only contributed to the company's portfolio but has also had a broader impact on the industry by improving the quality and reliability of pharmaceutical preparations.
Collaborations
Yoshiro has collaborated with notable colleagues, including Fumihide Nishio and Takuji Maejima. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.
Conclusion
Yoshiro Mitome's contributions to the field of pharmaceuticals, particularly through his patents on freeze-dried preparations containing high-purity PTH, demonstrate his commitment to innovation and excellence. His work continues to influence the industry and improve the quality of pharmaceutical products.
